Truist Financial Corp Anika Therapeutics, Inc. Transaction History

Truist Financial Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$32.49 - $45.96 $678,456 - $959,736	-20,882 Closed	0 $0
Q4 2020 Nov 19, 2021	SELL	$32.59 - $45.26 $38,195 - $53,044	-1,172 Reduced 5.31%	20,882 $946,000
Q4 2020 Feb 18, 2021	BUY	$32.59 - $45.26 $41,226 - $57,253	1,265 Added 6.08%	22,054 $999,000
Q3 2020 Nov 13, 2020	BUY	$32.56 - $38.57 $68,506 - $81,151	2,104 Added 11.26%	20,789 $737,000
Q2 2020 Aug 14, 2020	SELL	$27.83 - $37.73 $48,368 - $65,574	-1,738 Reduced 8.51%	18,685 $705,000
Q1 2020 May 15, 2020	BUY	$22.38 - $54.06 $92,630 - $223,754	4,139 Added 25.42%	20,423 $590,000
Q4 2019 Feb 14, 2020	BUY	$51.85 - $73.36 $844,325 - $1.19 Million	16,284 New	16,284 $844,000

123

11.5M

200

100

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $236M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.